Company Filing History:
Years Active: 2020-2023
Title: The Innovative Contributions of Travis S. Schlappi
Introduction
Travis S. Schlappi is a notable inventor based in Pasadena, California, recognized for his significant contributions to the field of microfluidics and antimicrobial susceptibility testing. With a total of three patents to his name, Schlappi has made strides in developing methods and devices that enhance our understanding of organism responses to various treatments.
Latest Patents
Among his latest patents, one focuses on "Microfluidic measurements of the response of an organism to a drug." This patent discloses methods and devices for the rapid assessment of whether a microorganism present in a sample is susceptible or resistant to a treatment. Another significant patent is titled "Digital quantification of DNA replication and/or chromosome segregation based determination of antimicrobial susceptibility." This invention outlines methods and devices that utilize digital isothermal amplification to detect subtle responses to environmental stimuli, particularly in determining antibiotic susceptibility.
Career Highlights
Travis Schlappi has worked with prestigious organizations, including the California Institute of Technology and Talis Biomedical Corporation. His work in these institutions has allowed him to push the boundaries of research and innovation in his field.
Collaborations
Throughout his career, Schlappi has collaborated with esteemed colleagues such as Rustem F. Ismagilov and Nathan G. Schoepp. These collaborations have further enriched his research and contributed to the advancement of technology in microbiology.
Conclusion
Travis S. Schlappi's innovative work and patents have significantly impacted the fields of microfluidics and antimicrobial susceptibility testing. His contributions continue to pave the way for advancements in medical and scientific research.